CAJ | 학술논문

将90例伴有胃肠道症状、幽门螺杆菌(Hp)阳性的2型糖尿病患者分为莫西沙星组和对照组,给予Hp根除治疗.结果显示,莫西沙星组较对照组胃肠道症状改善明显、不良反应发生率少、Hp根除率高,均P<0.05;治疗前两组的平均空腹血糖及餐后2 h血糖、糖化血红蛋白比较差异无统计学意义(P>0.05);治疗后莫西沙星组3个月的平均空腹血糖、餐后2 h血糖、糖化血红蛋白明显优于对照组(P<0.05).提示以莫西沙星为基础的三联疗法对根除2型糖尿病患者Hp感染有很好的疗效,并有利于血糖的控制.
장90례반유위장도증상、유문라간균(Hp)양성적2형당뇨병환자분위막서사성조화대조조,급여Hp근제치료.결과 현시,막서사성조교대조조위장도증상개선명현、불량반응발생솔소、Hp근제솔고,균P<0.05;치료전량조적평균공복혈당급찬후2 h혈당、당화혈홍단백비교차이무통계학의의(P>0.05);치료후막서사성조3개월적평균공복혈당、찬후2 h혈당、당화혈홍단백명현우우대조조(P<0.05).제시이막서사성위기출적삼련요법대근제2형당뇨병환자Hp감염유흔호적료효,병유리우혈당적공제.
Alc in trial group were significant better than those in control group ( P < 0. 05 ). The results indicate that type 2 diabetic patients with Hp infection should receive moxifloxacin-based triple therapy as first-line treatment.